Abstract
[Extract] The medical research world is responding to the covid-19
pandemic at breathtaking speed. There has been a maelstrom
of global research, with mixed consequences. Positives include
the greater provision of open access to covid-19 studies, some
increased collaboration, expedited governance and ethics
approvals of new clinical studies, and wider use of preprints.
But many problems have become evident. Before the pandemic,
it was estimated that up to 85% of research was wasted because
of poor questions, poor study design, inefficiency of regulation
and conduct, and non or poor reporting of results.1
Many of
these problems are amplified in covid-19 research, with time
pressures and inadequate research infrastructure contributing.
pandemic at breathtaking speed. There has been a maelstrom
of global research, with mixed consequences. Positives include
the greater provision of open access to covid-19 studies, some
increased collaboration, expedited governance and ethics
approvals of new clinical studies, and wider use of preprints.
But many problems have become evident. Before the pandemic,
it was estimated that up to 85% of research was wasted because
of poor questions, poor study design, inefficiency of regulation
and conduct, and non or poor reporting of results.1
Many of
these problems are amplified in covid-19 research, with time
pressures and inadequate research infrastructure contributing.
| Original language | English |
|---|---|
| Article number | m1847 |
| Number of pages | 2 |
| Journal | BMJ (Clinical research ed.) |
| Volume | 369 |
| DOIs | |
| Publication status | Published - 12 May 2020 |